CNS pipeline · person
Adam Koppel, MD, PhD
Director of Cerevel Therapeutics since September 2018, nominated to the board by BC Perception Holdings (Bain Capital). Partner of Bain Capital Life Sciences; previously executive vice president of corporate development and chief strategy officer at Biogen.
- 1 company
Courtesy Cerevel Therapeutics
Current roles
- Cerevel Therapeutics Holdings, Inc.Director · Board2018–present
Appears with
People sharing a company with Adam.
- Christopher Gordon · Cerevel Therapeutics Holdings, Inc.
- Deborah Baron · Cerevel Therapeutics Holdings, Inc.
- Deval Patrick · Cerevel Therapeutics Holdings, Inc.
- Doug Giordano · Cerevel Therapeutics Holdings, Inc.
- Gabrielle Sulzberger · Cerevel Therapeutics Holdings, Inc.
- John Renger · Cerevel Therapeutics Holdings, Inc.
- Kathleen Tregoning · Cerevel Therapeutics Holdings, Inc.
- Kenneth DiPietro · Cerevel Therapeutics Holdings, Inc.
- Marijn Dekkers · Cerevel Therapeutics Holdings, Inc.
- Mark Bodenrader · Cerevel Therapeutics Holdings, Inc.
- N. Anthony Coles · Cerevel Therapeutics Holdings, Inc.
- Norbert G. Riedel · Cerevel Therapeutics Holdings, Inc.
- Paul Burgess · Cerevel Therapeutics Holdings, Inc.
- Raymond Sanchez · Cerevel Therapeutics Holdings, Inc.
- Ron Renaud · Cerevel Therapeutics Holdings, Inc.
- Ruth McKernan · Cerevel Therapeutics Holdings, Inc.
- Scott Akamine · Cerevel Therapeutics Holdings, Inc.
- Suneet Varma · Cerevel Therapeutics Holdings, Inc.
- Susan Altschuller · Cerevel Therapeutics Holdings, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.